Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cleavage and Blastulation01:33

Cleavage and Blastulation

After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Zygotic Development And Stem Cell Formation01:10

Zygotic Development And Stem Cell Formation

The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy.

NPJ precision oncology·2026
Same author

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Breast (Edinburgh, Scotland)·2026
Same author

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

The oncologist·2026
Same author

Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Childhood adversity, allostatic load and epigenetic signatures in paediatric and adult-onset multiple sclerosis.

Brain communications·2026
Same author

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2.

Breast (Edinburgh, Scotland)·2026

Related Experiment Video

Updated: Jul 18, 2026

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
14:08

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development

Published on: January 26, 2013

Insights on blastomere nuclearity.

Mónica Gil1, Gustavo D'Ommar, Maria E Póo

  • 1Clínica de Fertilidad, Centro Médico Docente La Trinidad, Caracas, Venezuela. mgilco@cantv.net

Journal of Assisted Reproduction and Genetics
|December 21, 2006
PubMed
Summary

Embryos with multinucleated (MN) blastomeres that become mono-nucleated ("corrected") may lead to more successful pregnancies. Daily nuclear observation can help select better embryos for transfer, improving implantation rates.

More Related Videos

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

Related Experiment Videos

Last Updated: Jul 18, 2026

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
14:08

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development

Published on: January 26, 2013

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

Area of Science:

  • Reproductive medicine
  • Embryology
  • In vitro fertilization (IVF)

Background:

  • Embryo development and viability are crucial for successful IVF outcomes.
  • Blastomere nuclearity, specifically multinucleation (MN), is a factor that can affect embryo quality.
  • Understanding the developmental potential of MN embryos is important for improving IVF success rates.

Purpose of the Study:

  • To analyze the outcomes of transferred embryos, focusing on those that transitioned from multinucleated (MN) to mono-nucleated blastomeres.
  • To evaluate the impact of blastomere nuclearity changes on pregnancy and implantation rates in IVF cycles.

Main Methods:

  • Retrospective analysis of 633 IVF transfer cycles where at least one MN embryo was transferred.
  • Classification of embryos into normal (all mono-nucleated), corrected (MN to mono-nucleated), and non-corrected (persistent MN).
  • Comparison of pregnancy and implantation rates between cycles with exclusively mono-nucleated embryos and those with at least one MN embryo.

Main Results:

  • Pregnancy and implantation rates were similar between exclusively mono-nucleated embryo transfers (29.0% and 19.0%) and transfers including at least one MN embryo (28.6% and 15.8%).
  • Outcomes for 'corrected' and 'non-corrected' embryos were assessed in 9 cases, resulting in 8 and 4 normal babies, respectively.
  • A trend suggested higher rates of normal term pregnancies from 'corrected' embryos compared to 'non-corrected' ones, though not statistically significant due to limited data.

Conclusions:

  • While not statistically significant, a trend suggests 'corrected' embryos (MN to mono-nucleated) may yield better pregnancy outcomes than 'non-corrected' ones.
  • Daily monitoring of blastomere nuclearity is recommended as a strategy to improve embryo selection for transfer.
  • Improved embryo selection based on nuclear status could enhance implantation rates and potentially reduce multiple pregnancies.